Atopic dermatitis remains one of the most burdensome inflammatory skin diseases worldwide, with a substantial effect on ...

Arcutis Canada, Inc., a commercial stage company focused on delivering meaningful innovations in immuno-dermatology, today announced that Health Canada has approved PrZORYVE® (roflumilast) cream 0.05% ...

Facial eczema can be difficult to manage. Learn common skin-care mistakes that may trigger atopic dermatitis flare-ups and ...

Learn which ingredients to avoid and how to build a skin-care routine that supports your skin barrier when you have atopic dermatitis.

Atopic dermatitis biomarkers may reveal disease severity and hidden inflammation. Read more about the findings.

Atopic dermatitis affects an estimated 16.5 million adults and nearly 10 million children in the US, and more than half of ...

Early response to ivarmacitinib for the treatment of AD was associated with greater long-term efficacy compared with those without early response.

Autoimmune disease therapeutics market is projected to reach USD 262.0 Bn by 2036, expanding at a CAGR of 6.3% from 2026 to ...

The risk for contracting herpes zoster was elevated in people with atopic dermatitis, independent of comorbidities and ...

Individuals with atopic dermatitis had an increased risk for herpes zoster, and minimal reductions in the association were seen with adjustments for different definitions of oral corticosteroid ...

The research is part of MotherToBaby Pregnancy Studies’ ongoing commitment to generating evidence that helps patients and healthcare providers make informed decisions about medication use during ...

“This study adds to the body of evidence indicating that targeting inflammatory pathways improves microbiome dysregulation in the skin of patients with AD,” the authors wrote. “Immunomodulatory ...